Advanced search
Publication Cover
Leukemia & Lymphoma Volume 59, 2018 - Issue 4
Submit an article Journal homepage
468
Views
8
CrossRef citations to date
0
Altmetric
Original Articles: Research

The initial level of MLL-partial tandem duplication affects the clinical outcomes in patients with acute myeloid leukemia

Jun KongBeijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital, Institute of Hematology, Beijing, People’s Republic of ChinaORCID Iconhttp://orcid.org/0000-0002-9398-8526View further author information
ORCID Icon,
Xiao-Su ZhaoBeijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital, Institute of Hematology, Beijing, People’s Republic of ChinaView further author information
,
Ya-Zhen QinBeijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital, Institute of Hematology, Beijing, People’s Republic of ChinaView further author information
,
Hong-Hu ZhuBeijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital, Institute of Hematology, Beijing, People’s Republic of ChinaView further author information
,
Jin-Song JiaBeijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital, Institute of Hematology, Beijing, People’s Republic of ChinaView further author information
,
Qian JiangBeijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital, Institute of Hematology, Beijing, People’s Republic of ChinaView further author information
,
Jing WangBeijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital, Institute of Hematology, Beijing, People’s Republic of ChinaView further author information
,
Ting ZhaoBeijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital, Institute of Hematology, Beijing, People’s Republic of ChinaView further author information
,
Xiao-Jun HuangBeijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital, Institute of Hematology, Beijing, People’s Republic of ChinaORCID Iconhttp://orcid.org/0000-0002-2145-6643View further author information
ORCID Icon &
Hao JiangBeijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital, Institute of Hematology, Beijing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Pages 967-972 | Received 16 Oct 2016, Accepted 01 Jul 2017, Published online: 26 Jul 2017

References

  • Poppe B, Vandesompele J, Schoch C, et al. Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies. Blood. 2004;103:229–235.
  • Schichman SA, Caligiuri MA, Gu Y, et al. ALL-1 partial duplication in acute leukemia. Proc Natl Acad Sci USA. 1994;91:6236–6239.
  • Caligiuri MA, Schichman SA, Strout MP, et al. Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocations. Cancer Res. 1994;54:370–373.
  • Meyer C, Hofmann J, Burmeister T, et al. The MLL recombinome of acute leukemias in 2013. Leukemia. 2013;27:2165–2176.
  • Shih LY, Liang DC, Fu JF, et al. Characterization of fusion partner genes in 114 patients with de novo acute myeloid leukemia and MLL rearrangement. Leukemia. 2006;20:218–223.
  • Steudel C, Wermke M, Schaich M, et al. Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia. Genes Chromosom Cancer. 2003;37:237–251.
  • Whitman SP, Ruppert AS, Marcucci G, et al. Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication: a Cancer and Leukemia Group B study. Blood. 2007;109:5164–5167.
  • Döhner K, Tobis K, Ulrich R, et al. Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm. JCO. 2002;20:3254–3261.
  • Patel JP, Gönen M, Figueroa ME, et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med. 2012;366:1079–1089.
  • Caligiuri MA, Strout MP, Lawrence D, et al. Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics. Cancer Res. 1998;58:55–59.
  • Schnittger S, Kinkelin U, Schoch C, et al. Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML. Leukemia. 2000;14:796–804.
  • Ommen HB, Hokland P, Haferlach T, et al. Relapse kinetics in acute myeloid leukaemias with MLL translocations or partial tandem duplications within the MLL gene. Br J Haematol. 2014;165:618–628.
  • O’Donnell MR, Tallman MS, Abboud CN, et al. National Comprehensive Cancer Network. Acute myeloid leukemia, version 2.2013. J Natl Compr Canc Netw. 2013;11:1047–1055.
  • He Y, Wang D, Li X, et al. Expression of partial tandem duplication of mixed lineage leukaemia in patients with acute leukaemia and their relatives. Chin Med J. 2014;127:284–289.
  • Mohty M. Chapter 19: indication for HSCT in adults with acute myeloid leukaemia. In: Apperley J, Carreras E, Gluckman E, et al., editors. EBMT handbook 2012. Paris: European School of Haematology; 2012. p. 317–319.
  • Green CL, Koo KK, Hills RK, et al. Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations. JCO. 2010;28:2739–2747.
  • Taskesen E, Bullinger L, Corbacioglu A, et al. Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity. Blood. 2011;117:2469–2475.
  • Hou HA, Lin LI, Chen CY, et al. Reply to ‘Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favorable prognosis’. Br J Cancer. 2009;101:738–740.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.